TALPHERA, INC. — Director's Dealing 2023

Dec 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2023-12-13

Reporting Person: Angotti Vincent J. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-13	Common Stock	P	10000	$0.7268	Acquired	101805	Direct

Footnotes

F1: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.7198 to $0.73 on December 13, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.